Molecular portraits of human breast tumours
- PMID: 10963602
- DOI: 10.1038/35021093
Molecular portraits of human breast tumours
Abstract
Human breast tumours are diverse in their natural history and in their responsiveness to treatments. Variation in transcriptional programs accounts for much of the biological diversity of human cells and tumours. In each cell, signal transduction and regulatory systems transduce information from the cell's identity to its environmental status, thereby controlling the level of expression of every gene in the genome. Here we have characterized variation in gene expression patterns in a set of 65 surgical specimens of human breast tumours from 42 different individuals, using complementary DNA microarrays representing 8,102 human genes. These patterns provided a distinctive molecular portrait of each tumour. Twenty of the tumours were sampled twice, before and after a 16-week course of doxorubicin chemotherapy, and two tumours were paired with a lymph node metastasis from the same patient. Gene expression patterns in two tumour samples from the same individual were almost always more similar to each other than either was to any other sample. Sets of co-expressed genes were identified for which variation in messenger RNA levels could be related to specific features of physiological variation. The tumours could be classified into subtypes distinguished by pervasive differences in their gene expression patterns.
Similar articles
-
Semaphorin-plexin signalling genes associated with human breast tumourigenesis.Gene. 2011 Dec 10;489(2):63-9. doi: 10.1016/j.gene.2011.08.024. Epub 2011 Sep 2. Gene. 2011. PMID: 21925246
-
Microarrays in primary breast cancer--lessons from chemotherapy studies.Endocr Relat Cancer. 2001 Sep;8(3):259-63. doi: 10.1677/erc.0.0080259. Endocr Relat Cancer. 2001. PMID: 11566617
-
Systematic variation in gene expression patterns in human cancer cell lines.Nat Genet. 2000 Mar;24(3):227-35. doi: 10.1038/73432. Nat Genet. 2000. PMID: 10700174
-
Molecular profiling of breast cancer: portraits but not physiognomy.Breast Cancer Res. 2001;3(2):77-80. doi: 10.1186/bcr274. Epub 2000 Dec 18. Breast Cancer Res. 2001. PMID: 11250749 Free PMC article. Review.
-
Molecular portraits of breast cancer: tumour subtypes as distinct disease entities.Eur J Cancer. 2004 Dec;40(18):2667-75. doi: 10.1016/j.ejca.2004.08.021. Eur J Cancer. 2004. PMID: 15571950 Review.
Cited by
-
Comparative profiling of whole-cell and exosome samples reveals protein signatures that stratify breast cancer subtypes.Cell Mol Life Sci. 2024 Aug 22;81(1):363. doi: 10.1007/s00018-024-05403-z. Cell Mol Life Sci. 2024. PMID: 39172142
-
Sarmentosin alleviates doxorubicin-induced cardiotoxicity and ferroptosis via the p62-Keap1-Nrf2 pathway.Redox Rep. 2024 Dec;29(1):2392329. doi: 10.1080/13510002.2024.2392329. Epub 2024 Aug 16. Redox Rep. 2024. PMID: 39150892 Free PMC article.
-
Research hotspots and frontiers of neoadjuvant therapy in triple-negative breast cancer: a bibliometric analysis of publications between 2002 and 2023.Int J Surg. 2024 Aug 1;110(8):4976-4992. doi: 10.1097/JS9.0000000000001586. Int J Surg. 2024. PMID: 39143709 Free PMC article. Review.
-
A Research Protocol for a Phase II Single-Arm Clinical Trial Assessing the Feasibility and Efficacy of Neoadjuvant Anastrozole in Patients With Luminal Breast Cancer and Low Proliferative Index: The ANNE Trial.Cancer Control. 2024 Jan-Dec;31:10732748241272463. doi: 10.1177/10732748241272463. Cancer Control. 2024. PMID: 39140157 Free PMC article. Clinical Trial.
-
CD3-engaging bispecific antibodies trigger a paracrine regulated wave of T-cell recruitment for effective tumor killing.Commun Biol. 2024 Aug 13;7(1):983. doi: 10.1038/s42003-024-06682-9. Commun Biol. 2024. PMID: 39138287 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical